Astellas Launches Urinary Drug In Japan Ahead Of Europe, U.S.
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma launched its Betanis (betahistine) drug to treat overactive bladder in Japan, ahead of Europe and the United States where approval is expected next year